Inventor
BERND WEIGLE
Inventor
DE
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
12,509,522Polypeptides comprising immunoglobulin single variable domains targeting il-13 and OX40L202512,492,248Methods of treatment utilizing polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP202512,384,840Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP202511,840,566Methods of treating asthma with polypeptides targeting IL-13 and TSLP202311,208,476Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ABLYNX NV (5)· patent assignee history
2021–2025Patents assigned to SANOFI SA (5)· patent assignee history
2021–2025Based in DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABLYNX NV | 5 | 2021–2025 |
| SANOFI SA | 5 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 5 | 2021–2025 |